ProTrials Research, Inc., today announced that it has been selected as a finalist for the 5th annual Stevie Awards for Women in Business.
ProTrials Named Finalist In 5th Annual Stevie Awards
For Women In Business
Selection recognizes ProTrials client services and female leadership
Mountain View, CA – October 16, 2008 – ProTrials Research, Inc.TM, a leader in the clinical research organization industry, today announced that it has been selected as a finalist for the 5th annual Stevie Awards for Women in Business. The company is a finalist in the Best Overall Company of the Year-Service Businesses-up to 100 Employees category.
The Stevie Awards for Women in Business honor women executives, entrepreneurs, and the companies they run – worldwide. The Stevies have been hailed as the world’s premier business awards with its prestigious American Business Awards being called “the business world’s own Oscars” (New York Post, April 27, 2005).
“We are thrilled our peers selected ProTrials out of the 1,200 nominations in 50 categories worldwide,” said ProTrials CEO, Jodi Andrews. “It’s rewarding to be recognized for the outstanding services we provide our clients along with how we’ve paved the way for women in pharmaceutical research and development.”
ProTrials is owned and operated by two women-Jodi Andrews and Inger Arum. It recently made the Inc. 5000 list of the fastest-growing private companies in the United States and ranked seventh on the Silicon Valley/San Jose Business Journal’s list of the area’s Top 50 Women-Owned Businesses for 2008. This year, it attained certification by the Women’s Business Enterprise National Council, an elite group of women-owned and operated businesses.
“Being named a finalist in The Stevie Awards for Women in Business is an important achievement,” said Michael Gallagher, president of the Stevie Awards. “The nomination means independent business executives have agreed ProTrials is worthy of recognition. We congratulate all of the finalists on their achievement and wish them well in the competition.”
Business professionals worldwide selected finalists during preliminary judging. Members of the Awards' Board of Distinguished Judges & Advisors and their staffs will select Stevie Award winners from among the finalists during final judging. Winners will be announced during a gala event at the Marriott Marquis hotel in New York City on Friday, November 14.
More details about The Stevie Awards for Women in Business and the list of finalists in all categories are available at www.stevieawards.com/women <http://www.stevieawards.com/women> .
About ProTrials Research, Inc.
Founded in 1996, ProTrials Research, Inc. is a specialized contract research organization (CRO) with regional clinical research associates and project managers based throughout North America, Canada, and Europe. The company works with clients in the pharmaceutical, biotechnology and medical device industries, providing cost-effective site monitoring, project management and associated clinical operations services. ProTrials is headquartered in Mountain View, California. For more information, visit www.protrials.com <http://www.protrials.com/> or call (650) 864-9180.
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
February 13th 2025The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 fusion–positive cancers, particularly non-small cell lung cancer and pancreatic cancer.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.